Cantabio Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2018
June 17, 2019 at 02:19 pm EDT
Cantabio Pharmaceuticals Inc. announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced operating loss was USD 240,192 compared to USD 166,029 a year ago. Net income was USD 342,967 compared to net loss of USD 463,483 a year ago. Basic eps was USD 0 compared to basic loss per share of USD 0.02 a year ago. For the nine months, operating loss was USD 710,195 compared to USD 730,294 a year ago. Net loss was USD 692,512 compared to USD 1.161 million a year ago. Basic loss per share was USD 0.01 compared to USD 0.04 a year ago.